Atrium Therapeutics, Inc.

NASDAQ:RNA

Biotechnology

Healthcare
$6.98 +1.28%

+$0.16 today

Market cap
$150.57M
Beta
0.42
P/E (TTM)
-3.3
EPS (TTM)
-$3.78
52W Low $11.40High $16.77

Volume 0.23M

Average 0.35M

Price history

Atrium Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-52.68%

Period high

$16.54

Period low

$6.43

Latest

$6.98

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
8-KNov 2, 2026Nov 2, 2026
8-KOct 27, 2026Oct 27, 2026
8-K/AOct 9, 2026Oct 9, 2026
8-KOct 8, 2026Oct 8, 2026
4Sep 22, 2026Sep 22, 2026
4Sep 22, 2026Sep 22, 2026
4Sep 22, 2026Sep 22, 2026
4Sep 22, 2026Sep 22, 2026
4Sep 22, 2026Sep 22, 2026
4Sep 22, 2026Sep 22, 2026
4Sep 22, 2026Sep 22, 2026
4Sep 22, 2026Sep 22, 2026
SC 13G/AAug 14, 2026Aug 14, 2026

Competitors

Who does Atrium Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Questions

Filing questions

Common questions about RNA's filings, answered from its disclosures.

What is the latest RNA filing?

The latest filing shown is 8-K dated Nov 12, 2026.

How many recent filings does RNA have?

Intrinsic Alpha currently shows 20 recent filings for RNA.